EBI2 and key enzymes involved in 7α,25-dihydroxycholesterol synthesis are highly regulated during inflammation and could be involved in autoimmune diseases, cardiovascular diseases, neurodegenerative diseases, some metabolic diseases (dyslipidemia, obesity, and diabetes), in addition to some types of cancer and inflammation [62]. Here, GPR183 is linked to neurodegenerative disease.